Oppdatert: Wed, 29 Jun 2022 20:12:02
Tall fra FHI
Uke | Comirnaty 12+ (BioNTech/Pfizer) |
Comirnaty 5-11 år (BioNTech/Pfizer) |
Vaxzevria (AstraZeneca) |
Spikevax (Moderna) |
Nuvaxovid | Totalt per uke |
---|---|---|---|---|---|---|
2022-25 | 30 822 | 2 630 | 0 | 7 200 | 640 | 41 292 |
2022-24 | 10 218 | 950 | 0 | 3 400 | 330 | 14 898 |
2022-23 | 10 008 | 970 | 0 | 2 200 | 30 | 13 208 |
2022-22 | 12 240 | 1 370 | 0 | 2 800 | 200 | 16 610 |
2022-21 | 14 820 | 1 370 | 0 | 5 000 | 280 | 21 470 |
2022-20 | 9 594 | 900 | 0 | 1 400 | 220 | 12 114 |
2022-19 | 15 216 | 1 440 | 0 | 4 800 | 410 | 21 866 |
2022-18 | 15 558 | 1 130 | 0 | 4 000 | 340 | 21 028 |
2022-17 | 19 368 | 2 640 | 0 | 4 600 | 690 | 27 298 |
2022-16 | 0 | 0 | 0 | 2 000 | 0 | 2 000 |
2022-15 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-14 | 23 010 | 3 410 | 0 | 6 000 | 720 | 33 140 |
2022-13 | 10 140 | 820 | 0 | 600 | 400 | 11 960 |
2022-12 | 11 886 | 200 | 0 | 3 200 | 400 | 15 686 |
2022-11 | 8 454 | 60 | 0 | 800 | 360 | 9 674 |
2022-10 | 18 624 | 50 | 0 | 6 000 | 4 020 | 28 694 |
2022-09 | 20 790 | 110 | 0 | 2 400 | 0 | 23 300 |
2022-08 | 19 086 | 230 | 0 | 8 200 | 0 | 27 516 |
2022-07 | 52 608 | 140 | 0 | 8 600 | 0 | 61 348 |
2022-06 | 51 174 | 1 620 | 0 | 8 600 | 0 | 61 394 |
2022-05 | 48 132 | 30 040 | 0 | 11 400 | 0 | 89 572 |
2022-04 | 83 280 | 97 490 | 0 | 48 600 | 0 | 229 370 |
2022-03 | 291 756 | 40 | 0 | 141 000 | 0 | 432 796 |
2022-02 | 216 792 | 40 | 0 | 179 200 | 0 | 396 032 |
2022-01 | 125 778 | 20 | 0 | 148 500 | 0 | 274 928 |
2021-52 | 0 | 0 | 0 | 240 | 0 | 240 |
2021-51 | 369 480 | 3 400 | 0 | 347 600 | 0 | 720 480 |
2021-50 | 255 474 | 0 | 0 | 57 200 | 0 | 312 674 |
2021-49 | 256 356 | 0 | 0 | 19 600 | 0 | 275 956 |
2021-48 | 292 524 | 0 | 0 | 16 200 | 0 | 308 724 |
2021-47 | 192 450 | 0 | 0 | 18 400 | 0 | 210 850 |
2021-46 | 103 596 | 0 | 0 | 500 | 0 | 104 096 |
2021-45 | 105 408 | 0 | 0 | 700 | 0 | 106 108 |
2021-44 | 223 098 | 0 | 0 | 1 100 | 0 | 224 198 |
2021-43 | 23 220 | 0 | 0 | 1 800 | 0 | 25 020 |
2021-42 | 44 412 | 0 | 0 | 3 200 | 0 | 47 612 |
2021-41 | 39 606 | 0 | 0 | 9 400 | 0 | 49 006 |
2021-40 | 13 926 | 0 | 0 | 2 000 | 0 | 15 926 |
2021-39 | 30 072 | 0 | 0 | 7 300 | 0 | 37 372 |
2021-38 | 46 290 | 0 | 0 | 7 200 | 0 | 53 490 |
2021-37 | 190 380 | 0 | 0 | 9 600 | 0 | 199 980 |
2021-36 | 74 724 | 0 | 0 | 10 500 | 0 | 85 224 |
2021-35 | 25 254 | 0 | 0 | 197 200 | 0 | 222 454 |
2021-34 | 343 278 | 0 | 0 | 675 350 | 0 | 1 018 628 |
2021-33 | 333 054 | 0 | 0 | 53 400 | 0 | 386 454 |
2021-32 | 252 210 | 0 | 0 | 59 100 | 0 | 311 310 |
2021-31 | 196 128 | 0 | 0 | 52 200 | 0 | 248 328 |
2021-30 | 294 990 | 0 | 0 | 57 700 | 0 | 352 690 |
2021-29 | 212 976 | 0 | 0 | 55 200 | 0 | 268 176 |
2021-28 | 206 850 | 0 | 0 | 59 400 | 0 | 266 250 |
2021-27 | 206 350 | 0 | 0 | 37 000 | 0 | 243 350 |
2021-26 | 340 944 | 0 | 0 | 40 900 | 0 | 381 844 |
2021-25 | 343 398 | 0 | 0 | 37 100 | 0 | 380 498 |
2021-24 | 270 630 | 0 | 0 | 36 000 | 0 | 306 630 |
2021-23 | 263 712 | 0 | 0 | 40 300 | 0 | 304 012 |
2021-22 | 304 722 | 0 | 0 | 53 800 | 0 | 358 522 |
2021-21 | 198 606 | 0 | 0 | 48 000 | 0 | 246 606 |
2021-20 | 178 914 | 0 | 0 | 1 300 | 0 | 180 214 |
2021-19 | 185 226 | 0 | 0 | 50 500 | 0 | 235 726 |
2021-18 | 187 204 | 0 | 0 | 13 400 | 0 | 200 604 |
2021-17 | 208 620 | 0 | 0 | 15 600 | 0 | 224 220 |
2021-16 | 140 946 | 0 | 0 | 1 400 | 0 | 142 346 |
2021-15 | 150 930 | 0 | 0 | 49 500 | 0 | 200 430 |
2021-14 | 146 562 | 0 | 0 | 200 | 0 | 146 762 |
2021-13 | 86 198 | 0 | 0 | 29 100 | 0 | 115 298 |
2021-12 | 96 700 | 0 | 0 | 24 800 | 0 | 121 500 |
2021-11 | 54 990 | 0 | 0 | 15 000 | 0 | 69 990 |
2021-10 | 55 308 | 0 | 51 800 | 10 100 | 0 | 117 208 |
2021-09 | 55 308 | 0 | 40 900 | 9 800 | 0 | 106 008 |
2021-08 | 69 258 | 0 | 43 200 | 0 | 0 | 112 458 |
2021-07 | 67 152 | 0 | 6 800 | 0 | 0 | 73 952 |
2021-06 | 74 964 | 0 | 36 500 | 11 800 | 0 | 123 264 |
2021-05 | 95 358 | 0 | 0 | 0 | 0 | 95 358 |
2021-04 | 47 618 | 0 | 0 | 0 | 0 | 47 618 |
2021-03 | 28 470 | 0 | 0 | 0 | 0 | 28 470 |
2021-02 | 28 722 | 0 | 0 | 1 800 | 0 | 30 522 |
2021-01 | 17 750 | 0 | 0 | 0 | 0 | 17 750 |
2020-53 | 2 043 | 0 | 0 | 0 | 0 | 2 043 |
2020-52 | 5 | 0 | 0 | 0 | 0 | 5 |